These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20869735)

  • 1. [Local antitumor treatments].
    Menei P; Metellus P
    Neurochirurgie; 2010 Dec; 56(6):483-5. PubMed ID: 20869735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.
    Olivi A; Brem H
    Recent Results Cancer Res; 1994; 135():149-54. PubMed ID: 8047689
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results for Treatment of Newly-Diagnosed Glioblastoma Using Carmustine Wafers(Gliadel
    Kumabe T; Shibahara I; Saito R
    No Shinkei Geka; 2018 May; 46(5):367-376. PubMed ID: 29794312
    [No Abstract]   [Full Text] [Related]  

  • 5. Gliadel wafers acting as a lattice for bacterial growth: a case illustration.
    Muntasser H; Liaquat I; Barlow A; Whittle I
    Acta Neurochir (Wien); 2011 Oct; 153(10):2099-100. PubMed ID: 21800107
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of Gliadel wafers in the treatment of high-grade gliomas.
    Bregy A; Shah AH; Diaz MV; Pierce HE; Ames PL; Diaz D; Komotar RJ
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1453-61. PubMed ID: 24236823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
    Kunwar S; Chang S; Westphal M; Vogelbaum M; Sampson J; Barnett G; Shaffrey M; Ram Z; Piepmeier J; Prados M; Croteau D; Pedain C; Leland P; Husain SR; Joshi BH; Puri RK;
    Neuro Oncol; 2010 Aug; 12(8):871-81. PubMed ID: 20511192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy in glioblastomas: false steps and real advances.
    Brandes AA; Tosoni A; Franceschi E
    Expert Rev Anticancer Ther; 2007 May; 7(5):607-8. PubMed ID: 17492923
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral edema associated with Gliadel wafers: two case studies.
    Weber EL; Goebel EA
    Neuro Oncol; 2005 Jan; 7(1):84-9. PubMed ID: 15701285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation--incidence, therapeutic strategies, and outcome.
    Dörner L; Ulmer S; Rohr A; Mehdorn HM; Nabavi A
    J Clin Neurosci; 2011 Mar; 18(3):347-51. PubMed ID: 21237660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of polyanhydrides for drug delivery applications.
    Tamada J; Langer R
    J Biomater Sci Polym Ed; 1992; 3(4):315-53. PubMed ID: 1350734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [II. Current status of BCNU stent in the brain for treatment of glioma].
    Aoki T; Yamada S
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):708-17. PubMed ID: 23957061
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma.
    Ulmer S; Spalek K; Nabavi A; Schultka S; Mehdorn HM; Kesari S; Dörner L
    Neuro Oncol; 2012 Apr; 14(4):482-90. PubMed ID: 22319220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.
    Sardi I; Sanzo M; Giordano F; Sandri A; Mussa F; Donati PA; Genitori L
    Oncol Rep; 2008 May; 19(5):1219-23. PubMed ID: 18425379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma--more questions than answers?
    Reardon DA
    Nat Clin Pract Oncol; 2006 Feb; 3(2):60-1. PubMed ID: 16462825
    [No Abstract]   [Full Text] [Related]  

  • 18. Carmustine wafers (Gliadel) plus concomitant temozolomide therapy after resection of malignant astrocytoma: growing evidence for safety and efficacy.
    McGirt MJ; Brem H
    Ann Surg Oncol; 2010 Jul; 17(7):1729-31. PubMed ID: 20422453
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors.
    Domb AJ; Israel ZH; Elmalak O; Teomim D; Bentolila A
    Pharm Res; 1999 May; 16(5):762-5. PubMed ID: 10350022
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.